Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.

Journal of inherited metabolic disease - 1 Oct 2011

Muñoz-Rojas María Verónica, Bay Luisa, Sanchez Luz, van Kuijck Marcel, Ospina Sandra, Cabello Juan Francisco, Martins Ana Maria

Abstract excerpt

BACKGROUND: Mucopolysaccharidosis I (MPS I) comprises a spectrum of clinical manifestations and is divided into three phenotypes reflecting clinical severity: Hurler, Hurler-Scheie, and Scheie syndromes. There may be important variations in clinical manifestations of this genetic disease in patients residing in different regions of the world. METHODS: Using data from the MPS I Registry (as of September 2009), we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comorbidity
Share to Enzyme Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Global Health

Share to Hematopoietic Stem Cell Transplantation

Share to Iduronidase

Share to Latin America

Share to Mucopolysaccharidosis I

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 21541721
DOI: 10.1007/s10545-011-9336-2
PMCID: PMC3173625

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.PMID 21541721Read ↗

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.Semantic proximity Read ↗

The natural history of MPS I: global perspectives from the MPS I Registry.Semantic proximity Read ↗

Mucopolysaccharidosis VII in Brazil: Natural History and Clinical FindingsSemantic proximity Read ↗

Mucopolysaccharidosis Type ISemantic proximity Read ↗

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseSemantic proximity Read ↗

The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centersSemantic proximity Read ↗

The Landscape of Mucopolysaccharidosis in Southern and Eastern European Countries: A Survey from 19 Specialistic Centers.Semantic proximity Read ↗

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatmentSemantic proximity Read ↗

Mucopolysaccharidosis VII in Brazil: natural history and clinical findings.Semantic proximity Read ↗

Growth patterns for untreated individuals with MPS I: Report from the international MPS I registry.Semantic proximity Read ↗

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Semantic proximity Read ↗

Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.